XWELL Sets October 28 Vote on $13M Sale of XpresSpa and XpresTest
XWEL has more than doubled off its 52-week low of $0.255.
Summary
XWELL's definitive proxy sets an October 28 shareholder vote on the $13 million sale of its XpresSpa and XpresTest businesses, with the board and key holders already backing the deal.
Key Events · M&A and Partnerships · XWEL
-
Special Meeting Set for October 28
Shareholders will vote on the $13 million sale of XpresSpa and XpresTest to Express Wellness Group, with a record date of October 7, 2026.
-
Board and Support Parties Back Deal
The board unanimously recommends approval, and support parties holding approximately 28.1% of outstanding shares have agreed to vote in favor.
-
New Equity Plan Proposal Added
The proxy includes a proposal to increase the 2020 Equity Incentive Plan reserve from 3,125,000 to 4,346,134 shares.
-
XpresTest RSAs Repurchased Early
On October 5, 2026, XpresTest repurchased all outstanding restricted stock awards for approximately $2.7 million at $9,634.09 per share, simplifying its capitalization before closing.
Analysis · XWEL · Trade & Services
The definitive proxy statement finalizes the shareholder vote on the $13 million sale of XWELL's airport spa and biosurveillance businesses to Express Wellness Group. The meeting is set for October 28, 2026, with a record date of October 7. The board unanimously recommends approval, and support parties controlling roughly 28.1% of shares have already agreed to vote in favor. The filing also adds a new proposal to increase the 2020 equity plan by 1.2 million shares, and discloses that XpresTest restricted stock awards were repurchased early for about $2.7 million at $9,634.09 per share. For a company with a market cap near $7.7 million, the $13 million sale is transformative — it would leave XWELL with only its smaller ex-airport retail business and a large cash balance to pursue a new strategy.
How filings like this one have moved
In the 30 days to Oct 8, 2026, 28.8% of the 1732 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XWEL was trading at $0.85 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $7.7M. The 52-week trading range was $0.26 to $2.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.